Data Dive Into NK-1 Antagonists & Carboplatin

OncoPharm
07/11/2019 17 min
Data Dive Into NK-1 Antagonists & Carboplatin

Listen "Data Dive Into NK-1 Antagonists & Carboplatin"

Descargar episodio Ver en sitio original

Episode Synopsis

ASCO's updated 2017 antiemetic guidelines recommend NK-1 antagonists to prevent CINV with standard Q 3 week carboplatin (i.e. AUC 5-6), but how good are the data to support that? We dive into the supporting data.
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA